Gene · 1459
Papers2,405
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,405
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating tumor cell-derived preclinical models: current status and future perspectives. | Cell Death Dis | 2023 | 37591867 | PubTator, text mining | PubMed |
| m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. | Mol Cancer | 2023 | 37582735 | PubTator, text mining | PubMed |
| Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies. | PLoS One | 2023 | 37578958 | PubTator, text mining | PubMed |
| Enzyme-based assay for quantification of UDP-GlcNAc in cells and tissues. | Cell Rep Methods | 2023 | 37533649 | PubTator, text mining | PubMed |
| Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation. | Cell Rep Methods | 2023 | 37533645 | PubTator, text mining | PubMed |
| Key role of phosphorylation sites in ATPase domain and Linker region of MLH1 for DNA binding and functionality of MutLα. | Sci Rep | 2023 | 37532794 | PubTator, text mining | PubMed |
| Aberrations in ion channels interacting with lipid metabolism and epithelial-mesenchymal transition in esophageal squamous cell carcinoma. | Front Mol Biosci | 2023 | 37529379 | PubTator, text mining | PubMed |
| The Beneficial and Adverse Effects of Autophagic Response to Caloric Restriction and Fasting. | Adv Nutr | 2023 | 37527766 | PubTator, text mining | PubMed |
| SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the CK2-mediated MAPK/ERK and PI3K/AKT pathways. | Exp Mol Med | 2023 | 37524874 | PubTator, text mining | PubMed |
| Synthesis and Anticancer Activity of Novel Dual Inhibitors of Human Protein Kinases CK2 and PIM-1. | Pharmaceutics | 2023 | 37514177 | PubTator, text mining | PubMed |
| Impact of Protein Nα-Modifications on Cellular Functions and Human Health. | Life (Basel) | 2023 | 37511988 | PubTator, text mining | PubMed |
| Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 37509370 | PubTator, text mining | PubMed |
| TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | Biochim Biophys Acta Mol Cell Res | 2023 | 37506885 | PubTator, text mining | PubMed |
| Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma. | Cancer Chemother Pharmacol | 2023 | 37491611 | PubTator, text mining | PubMed |
| Emodin attenuates high lipid-induced liver metastasis through the AKT and ERK pathways in vitro in breast cancer cells and in a mouse xenograft model. | Heliyon | 2023 | 37484373 | PubTator, text mining | PubMed |
| Rapid phosphorylation of glucose-6-phosphate dehydrogenase by casein kinase 2 sustains redox homeostasis under ionizing radiation. | Redox Biol | 2023 | 37478541 | PubTator, text mining | PubMed |
| Beta-Secretase 1 Recruits Amyloid-Beta Precursor Protein to ROCK2 Kinase, Resulting in Erroneous Phosphorylation and Beta-Amyloid Plaque Formation. | Int J Mol Sci | 2023 | 37445593 | PubTator, text mining | PubMed |
| Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis. | Noncoding RNA Res | 2023 | 37434946 | PubTator, text mining | PubMed |
| Identification of hub genes and microRNAs with prognostic values in esophageal cancer by integrated analysis. | Noncoding RNA Res | 2023 | 37416747 | PubTator, text mining | PubMed |
| O-GlcNAc Dynamics: The Sweet Side of Protein Trafficking Regulation in Mammalian Cells. | Cells | 2023 | 37408229 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1459/papers?page=9